Nasdaq‑listed Huron, the US‑based global professional services firm, has acquired RelateCare, an Ireland‑headquartered provider of AI‑enabled clinical and patient access solutions, from MML Ireland. The deal enhances Huron’s ability to deliver comprehensive healthcare managed services aimed at improving patient access and care coordination.
“The acquisition of RelateCare creates a comprehensive...
Euronext-listed UCB, a Belgium-based global biopharmaceutical company, has acquired Neurona Therapeutics, a US-based clinical-stage biotherapeutics company developing regenerative cell therapies, for a total transaction valued of up to US$1.15bn consisting of a US$650m upfront payment plus up to US$500m in potential future milestone payments.
The transaction, which includes Neurona’s lead asset rezanecel – an investigational drug under phase l/ll investigation for drug-resistant mesial temporal lobe epilepsy - adds to UCB’s epilepsy portfolio and accelerates UCB’s entry into next-generation disease-modifying therapies and cell therapies.
Press release: UCB completes acquisition of Neurona Therapeutics,...